Chelsea, Australia

Kathryn Traci-Jane Klose

This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Acrux Dds Pty Ltd, Acrux Dds Pty Ltc.. Active years: 2005-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathryn Traci-Jane Klose. Retrieved from https://idiyas.com/inventor/kathryn-traci-jane-klose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 16.7


Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 290(Granted Patents)


Location History:

  • Chelsea, AU (2005)
  • Bonbeach, AU (2008)
  • Bonreach, AU (2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kathryn Traci-Jane Klose: Innovator in Transdermal Drug Delivery

Introduction

Kathryn Traci-Jane Klose is a prominent inventor based in Chelsea, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal drug delivery systems. With a total of 6 patents to her name, Klose has established herself as a key figure in innovative drug delivery technologies.

Latest Patents

Klose's latest patents include groundbreaking work on transdermal delivery rate control using amorphous pharmaceutical compositions. One notable invention is a pharmaceutical composition for transdermal delivery that focuses on the transdermal delivery of non-steroidal anti-inflammatory drugs. This invention provides a transdermal drug delivery system that comprises a therapeutically effective amount of a non-steroidal anti-inflammatory drug, at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester, and at least one volatile liquid. Additionally, the invention outlines a method for administering at least one systemic or locally acting non-steroidal anti-inflammatory drug to an animal, which involves applying an effective amount of the drug in the form of the innovative delivery system.

Career Highlights

Throughout her career, Klose has worked with various companies, including Acrux DDS Pty Ltd and Acrux DDS Pty Ltd. Her work has focused on enhancing the efficacy and safety of drug delivery methods, making significant strides in pharmaceutical technology.

Collaborations

Klose has collaborated with notable professionals in her field, including Barrie Charles Finnin and Barry Leonard Reed. These collaborations have contributed to her innovative approaches and advancements in drug delivery systems.

Conclusion

Kathryn Traci-Jane Klose is a trailblazer in the field of transdermal drug delivery, with a strong portfolio of patents and collaborations that highlight her expertise and commitment to innovation. Her work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…